Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane 9 superfamily member 3 (TM9SF3) is a multi-pass transmembrane protein in the nonaspanin family, predicted to be involved in protein trafficking to and localization at cellular membranes[1][3]. It is highly expressed in several tissues and is upregulated in certain cancers, particularly scirrhous-type gastric cancer and T-cell leukemia, where it promotes cell proliferation and invasion, supporting tumor aggressiveness and making it a prognostic biomarker in these malignancies[2][4]. While not currently a direct therapeutic target, its implication in cancer biology and membrane trafficking highlights its potential relevance in oncology research and biomarker development[2].
Not established; however, microRNA-1193 suppresses its expression, reducing proliferation and invasion, which implies that TM9SF3 supports these oncogenic processes when active[2]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane 9 superfamily member 3 (TM9SF3).